News
Pfizer Jab For Kids Under Five May Not Be Out Soon Says FDA
In a recent development, which is a kind of a setback in the case of inoculation for kids, the FDA has confirmed that it...
Press Releases
PHARMINTECH and IPACK-IMA: a synergic union
The 7thedition of Pharmintech Exhibition is goingto take place in Milan from May 3 to 6, 2022 in conjunction with IPACK-IMA, the most important...
News
WHO prequalifies first monoclonal antibody – tocilizumab – to treat COVID-19
Aiming to increase access to recommended treatments for COVID-19, WHO today added tocilizumab, a monoclonal antibody, to its list of prequalified treatments for COVID-19....
Press Releases
Glenmark inks agreement with AstraZeneca to commercialize its product Pulmicort Respules in Colombia
Glenmark Pharmaceuticals, an innovation–driven, global pharmaceutical company, announced that its subsidiary Glenmark Pharmaceuticals Colombia S.A.S. and AstraZeneca Colombia S.A.S. have entered into an exclusive...
Packaging & Labelling
Envirotainer introduces the RAP for the future – part of the Releye series
Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, launched its latest innovation, the Releye® RAP. This is...
Drug Research
BioGenes, Alphalyse partner to optimize ELISA reagent characterization for biomanufacturing
BioGenes has partnered with Alphalyse, a specialist contract research organization. Recently, two companies that have been active in the field of Host Cell Protein...
Press Releases
Lilly’s bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-moderate COVID-19
The U.S. FDA has issued an Emergency Use Authorization for bebtelovimab, an antibody that demonstrates neutralization against the Omicron variant, Eli Lilly and Company...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read